Multiple sclerosis. Demyelinating diseases of the central nervous system
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: All patients with MS who have Expanded Disability Status Scale (EDSS) equal or less than 4. Patients with MS aged 18 to 50 years old Informed consent
Exclusion criteria
Exclusion criteria: Use of other complementary and alternative methods during the study History of Hypothyroidism, hyperparathyroidism, hypopituitarism declared by the patient Sleeping and sedative medications, antidepressants and analgesics during the study Having problems with the legs, including problems with blood flow (confirmed by the cardiologist) The presence of burn, fungal infection, varicose veins, warts, corns and any kind of numbness in the leg The presence of deformity or ulcer in the area of massage on the plantar area Irritable bowel syndrome confirmed by a doctor Gastrointestinal obstructive diseases, inflammatory digestive diseases
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Constipation. Timepoint: At the beginning of the study and at the end of the sixth week after the intervention began. Method of measurement: Constipation Assessment Scale (CAS).;Quality of Life. Timepoint: At the beginning of the study and at the end of the sixth week after the intervention began. Method of measurement: Quality of life SF36 questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Arak University of Medical Sciences